Suppr超能文献

去神经支配的人胰腺中胰岛素分泌缺乏反馈抑制。

Lack of feedback inhibition of insulin secretion in denervated human pancreas.

作者信息

Luzi L, Battezzati A, Perseghin G, Bianchi E, Vergani S, Secchi A, La Rocca E, Staudacher C, Spotti D, Ferrari G

机构信息

Department of Internal Medicine, Istituto Scientifico San Raffaele, University of Milan, Italy.

出版信息

Diabetes. 1992 Dec;41(12):1632-9. doi: 10.2337/diab.41.12.1632.

Abstract

In this study, pancreas transplantation is used as a clinical model of pancreas denervation in humans. To assess the role of innervation on the feedback autoinhibition of insulin secretion, we studied four groups of subjects--group 1: 16 patients with combined pancreas and kidney transplantation (plasma glucose = 5.1 mM, HbA1c = 6.4%, creatinine = 86 mM); group 2: 8 patients with chronic uveitis on the same immunosuppressive therapy as transplanted patients (12 mg/day prednisone, 5 mg.kg-1.day-1 CsA); group 3: 4 uremic, nondiabetic patients in chronic hemodialysis; group 4: 7 normal, nondiabetic control subjects. The following means were used to study the groups: 1) a two-step hyperinsulinemic euglycemic clamp (insulin infusion rate = 1 mU and 5 mU.kg-1.min-1); and 2) a 0.3 mU.kg-1.min-1 hypoglycemic clamp (steady-state plasma glucose = 3.1 mM). Basal plasma-free IRI (84 +/- 6, 42 +/- 12, 72 +/- 12, and 30 +/- 6 pM in groups 1, 2, 3, and 4, respectively), basal C-peptide (0.79 +/- 0.05, 0.66 +/- 0.05, 3.04 +/- 0.20, and 0.59 +/- 0.06 nM in groups 1, 2, 3, and 4, respectively), and glucagon (105 +/- 13, 69 +/- 4, 171 +/- 10, and 71 +/- 5 pg/ml in groups 1, 2, 3, and 4, respectively) were increased in groups 1 and 3 with respect to groups 2 and 4 (P < 0.01). During euglycemic hyperinsulinemia, plasma C-peptide decreased by 45, 20, and 44% in groups 2, 3, and 4, respectively, but showed no significant change from the basal in patients with transplanted pancreases.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在本研究中,胰腺移植被用作人类胰腺去神经支配的临床模型。为评估神经支配对胰岛素分泌反馈性自身抑制的作用,我们研究了四组受试者:第一组:16例接受胰腺和肾脏联合移植的患者(血浆葡萄糖 = 5.1 mM,糖化血红蛋白 = 6.4%,肌酐 = 86 mM);第二组:8例患有慢性葡萄膜炎且接受与移植患者相同免疫抑制治疗的患者(泼尼松12 mg/天,环孢素5 mg·kg-1·天-1);第三组:4例慢性血液透析的尿毒症非糖尿病患者;第四组:7名正常非糖尿病对照受试者。采用以下方法对各组进行研究:1)两步高胰岛素正常血糖钳夹试验(胰岛素输注速率 = 1 mU和5 mU·kg-1·分钟-1);2)0.3 mU·kg-1·分钟-1的低血糖钳夹试验(稳态血浆葡萄糖 = 3.1 mM)。与第二组和第四组相比,第一组和第三组的基础血浆游离胰岛素原(分别为84±6、42±12、72±12和30±6 pM)、基础C肽(分别为0.79±0.05、0.66±0.05、3.04±0.20和0.59±0.06 nM)以及胰高血糖素(分别为105±13、69±4、171±10和71±5 pg/ml)均升高(P < 0.01)。在正常血糖高胰岛素血症期间,第二组、第三组和第四组的血浆C肽分别下降了45%、20%和44%,但胰腺移植患者的血浆C肽与基础值相比无显著变化。(摘要截短至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验